StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3037% above fair value
$82.31−1.14 (-1.37%)

Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –

IRadimed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

IRadimed's free cash flow for the twelve months ending Sep 30, 2026 was $26.14M, up 77.2% year over year. For fiscal 2025 it was $17.18M, down 2.5% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $17.62M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.18M-2.5%
FY2024Dec 31, 2024$17.62M+192.5%
FY2023Dec 31, 2023$6.02M-34.7%
FY2022Dec 31, 2022$9.22M-14.4%
FY2021Dec 31, 2021$10.78M+100.5%
FY2020Dec 31, 2020$5.37M-45.5%
FY2019Dec 31, 2019$9.86M+38.0%
FY2018Dec 31, 2018$7.15M+170.7%
FY2017Dec 31, 2017$2.64M-69.4%
FY2016Dec 31, 2016$8.63M+17.3%
FY2015Dec 31, 2015$7.35M+267.2%
FY2014Dec 31, 2014$2.00M+52.7%
FY2013Dec 31, 2013$1.31M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$6.87M+17.4%
Q2 FY2026Jun 30, 2026$5.76M+12.6%
Q1 FY2026Mar 31, 2026$7.89M+1225.5%
Q4 FY2025Dec 31, 2025$5.63M+76.1%
Q3 FY2025Sep 30, 2025$5.85M+10.2%
Q2 FY2025Jun 30, 2025$5.11M-7.1%
Q1 FY2025Mar 31, 2025$595.00K-83.5%
Q4 FY2024Dec 31, 2024$3.20M-5.4%
Q3 FY2024Sep 30, 2024$5.31M+389.2%
Q2 FY2024Jun 30, 2024$5.50M+66.3%
Q1 FY2024Mar 31, 2024$3.61M–
Q4 FY2023Dec 31, 2023$3.38M+21.6%
Q3 FY2023Sep 30, 2023$1.08M-71.0%
Q2 FY2023Jun 30, 2023$3.31M+128.1%
Q1 FY2023Mar 31, 2023-$1.75M-240.8%
Q4 FY2022Dec 31, 2022$2.78M-15.1%
Q3 FY2022Sep 30, 2022$3.75M+16.0%
Q2 FY2022Jun 30, 2022$1.45M-58.1%
Q1 FY2022Mar 31, 2022$1.24M+53.3%
Q4 FY2021Dec 31, 2021$3.28M+36.3%
Q3 FY2021Sep 30, 2021$3.23M+151.1%
Q2 FY2021Jun 30, 2021$3.46M+427.3%
Q1 FY2021Mar 31, 2021$810.76K-21.3%
Q4 FY2020Dec 31, 2020$2.40M-36.4%
Q3 FY2020Sep 30, 2020$1.29M-58.0%
Q2 FY2020Jun 30, 2020$656.63K-73.1%
Q1 FY2020Mar 31, 2020$1.03M+76.9%
Q4 FY2019Dec 31, 2019$3.78M+9.0%
Q3 FY2019Sep 30, 2019$3.06M+348.4%
Q2 FY2019Jun 30, 2019$2.44M+68.1%
Q1 FY2019Mar 31, 2019$582.26K-62.3%
Q4 FY2018Dec 31, 2018$3.46M+170.9%
Q3 FY2018Sep 30, 2018$682.65K-59.0%
Q2 FY2018Jun 30, 2018$1.45M+1104.7%
Q1 FY2018Mar 31, 2018$1.55M–
Q4 FY2017Dec 31, 2017$1.28M-35.7%
Q3 FY2017Sep 30, 2017$1.67M–
Q2 FY2017Jun 30, 2017$120.73K–
Q1 FY2017Mar 31, 2017-$425.05K–
Q4 FY2016Dec 31, 2016$1.99M–

More IRadimed figures

See a number that looks wrong?